Does Lp-PLA2 activity indicate arterial-wall inflammation and higher risk of coronary atherosclerotic events?

Lp-PLA2 (lipoprotein-associated phospholipase A2) serves as both a biochemical marker and a primary mediator of the inflammatory processes that drive atherosclerosis. It is particularly relevant for individuals in middle age, like the patient context provided, as it identifies risk often missed by traditional lipid panels.

Mechanistic Role in Vascular Inflammation

The enzyme's activity is a direct reflection of the interaction between lipid oxidation and arterial wall health.

• Oxidized Lipoprotein Hydrolysis: Lp-PLA2 specifically targets the sn-2 position of oxidized phospholipids within oxidized low-density lipoprotein (oxLDL).
• Pro-inflammatory Byproducts: This hydrolysis generates two potent bioactive lipids: lysophosphatidylcholine (lysoPC) and oxidized non-esterified fatty acids (oxNEFAs).
• Plaque Instability: These products drive endothelial dysfunction, recruit macrophages, and induce foam cell formation. Research on carotid endarterectomy tissues confirms a significant positive correlation (r = 0.497) between oxLDL and Lp-PLA2 presence, particularly in the necrotic cores of symptomatic plaques.

Clinical Evidence and Cardiovascular Risk

Lp-PLA2 activity is a validated independent predictor of future coronary events across broad populations.

• Predictive Power: Large-scale meta-analyses involving 32 prospective studies indicate a relative risk of approximately 1.10 per standard deviation increase in Lp-PLA2 activity for coronary heart disease (CHD). This risk persists even after adjusting for non-HDL cholesterol and blood pressure.
• Synergistic Effects: When combined with other markers like high-sensitivity C-reactive protein (hs-CRP), high levels of Lp-PLA2 activity significantly amplify risk. Patients in the highest tertiles of both markers show marked increases in hazard ratios (HR 1.33–1.36) for myocardial infarction and cardiovascular death.
• Correlation with Disease Severity: Elevated activity levels correlate with higher Gensini scores, indicating a more extensive burden of coronary artery disease.

Bottom line

Lp-PLA2 activity is a supported biomarker for arterial-wall inflammation and an independent predictor of coronary events, offering prognostic value that complements traditional risk factor assessment.